Cargando…
Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776352/ https://www.ncbi.nlm.nih.gov/pubmed/32079693 http://dx.doi.org/10.3324/haematol.2019.241539 |
| _version_ | 1783630662437175296 |
|---|---|
| author | Eyre, Toby A. Lamanna, Nicole Roeker, Lindsey E. Ujjani, Chaitra S Hill, Brian T. Barr, Paul M. Lansigan, Erick Cheson, Bruce D. Yazdy, Maryam Allan, John N. Rhodes, Joanna Schuster, Stephen J. Nabhan, Chadi Skarbnik, Alan Leslie, Lorie Islam, Prioty Whitaker, Katherine Coombs, Catherine C. Tuncer, Hande H. Pagel, John M. Jacobs, Ryan Winter, Allison M. Bailey, Neil Sitlinger, Andrea Schuh, Anna H. Follows, George Fox, Christopher P. Brander, Danielle M. Shadman, Mazyar Mato, Anthony R. |
| author_facet | Eyre, Toby A. Lamanna, Nicole Roeker, Lindsey E. Ujjani, Chaitra S Hill, Brian T. Barr, Paul M. Lansigan, Erick Cheson, Bruce D. Yazdy, Maryam Allan, John N. Rhodes, Joanna Schuster, Stephen J. Nabhan, Chadi Skarbnik, Alan Leslie, Lorie Islam, Prioty Whitaker, Katherine Coombs, Catherine C. Tuncer, Hande H. Pagel, John M. Jacobs, Ryan Winter, Allison M. Bailey, Neil Sitlinger, Andrea Schuh, Anna H. Follows, George Fox, Christopher P. Brander, Danielle M. Shadman, Mazyar Mato, Anthony R. |
| author_sort | Eyre, Toby A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7776352 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77763522021-01-07 Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia Eyre, Toby A. Lamanna, Nicole Roeker, Lindsey E. Ujjani, Chaitra S Hill, Brian T. Barr, Paul M. Lansigan, Erick Cheson, Bruce D. Yazdy, Maryam Allan, John N. Rhodes, Joanna Schuster, Stephen J. Nabhan, Chadi Skarbnik, Alan Leslie, Lorie Islam, Prioty Whitaker, Katherine Coombs, Catherine C. Tuncer, Hande H. Pagel, John M. Jacobs, Ryan Winter, Allison M. Bailey, Neil Sitlinger, Andrea Schuh, Anna H. Follows, George Fox, Christopher P. Brander, Danielle M. Shadman, Mazyar Mato, Anthony R. Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-02-20 /pmc/articles/PMC7776352/ /pubmed/32079693 http://dx.doi.org/10.3324/haematol.2019.241539 Text en Copyright© 2021 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Eyre, Toby A. Lamanna, Nicole Roeker, Lindsey E. Ujjani, Chaitra S Hill, Brian T. Barr, Paul M. Lansigan, Erick Cheson, Bruce D. Yazdy, Maryam Allan, John N. Rhodes, Joanna Schuster, Stephen J. Nabhan, Chadi Skarbnik, Alan Leslie, Lorie Islam, Prioty Whitaker, Katherine Coombs, Catherine C. Tuncer, Hande H. Pagel, John M. Jacobs, Ryan Winter, Allison M. Bailey, Neil Sitlinger, Andrea Schuh, Anna H. Follows, George Fox, Christopher P. Brander, Danielle M. Shadman, Mazyar Mato, Anthony R. Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia |
| title | Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia |
| title_full | Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia |
| title_fullStr | Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia |
| title_full_unstemmed | Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia |
| title_short | Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia |
| title_sort | comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776352/ https://www.ncbi.nlm.nih.gov/pubmed/32079693 http://dx.doi.org/10.3324/haematol.2019.241539 |
| work_keys_str_mv | AT eyretobya comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT lamannanicole comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT roekerlindseye comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT ujjanichaitras comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT hillbriant comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT barrpaulm comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT lansiganerick comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT chesonbruced comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT yazdymaryam comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT allanjohnn comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT rhodesjoanna comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT schusterstephenj comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT nabhanchadi comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT skarbnikalan comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT leslielorie comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT islamprioty comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT whitakerkatherine comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT coombscatherinec comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT tuncerhandeh comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT pageljohnm comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT jacobsryan comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT winterallisonm comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT baileyneil comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT sitlingerandrea comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT schuhannah comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT followsgeorge comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT foxchristopherp comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT branderdaniellem comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT shadmanmazyar comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia AT matoanthonyr comparativeanalysisoftargetednoveltherapiesinrelapsedrefractorychroniclymphocyticleukemia |